Stent Companies Begin Post-Meeting Spin

In the aftermath of a CDRH panel meeting that raised concerns about the safety of drug-eluting stents in high-risk patients, Johnson & Johnson and Boston Scientific have launched aggressive campaigns to raise awareness of doctors and patients, reports the Boston Globe. J&J has conducted a number of conference calls with doctors about stent safety, and Boston Scientific has put out a bunch of new information in print ads and on its Web site.